Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade

Characterization of host immune cell parameters before and during immunotherapy is expected to identify predictive biomarkers for clinical outcome. We prospectively monitored blood immune cells from 35 patients with advanced non–small cell lung cancer undergoing checkpoint inhibitor monotherapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Möller, Miriam, Turzer, Steffi, Schütte, Wolfgang, Seliger, Barbara, Riemann, Dagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012348/
https://www.ncbi.nlm.nih.gov/pubmed/31592989
http://dx.doi.org/10.1097/CJI.0000000000000297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012348/
https://www.ncbi.nlm.nih.gov/pubmed/31592989
http://dx.doi.org/10.1097/CJI.0000000000000297

Ejemplares similares